Charlie's Angel is a modern hybrid-indica variety derived from its parent, Jamaican Purple. Designed for cultivators seeking reliable performance, this strain features a moderate growth difficulty and a flowering period of 64 days. It is well-suited for both indoor and outdoor environments, consistently rewarding the grower with a high yield. Its genetic lineage is notable for having produced offspring back into the Jamaican Purple line.

The aromatic and flavor profile of Charlie's Angel is governed by a diverse chemical structure led by caryophyllene, myrcene, and limonene. Secondary and tertiary notes are provided by pinene, humulene, ocimene, and nerolidol, with trace contributions from linalool, beta-pinene, guaiol, p-cymene, bisabolol, eucalyptol, camphene, and caryophyllene-oxide. This specific interaction of terpenes informs the strain's sensory character, providing a complex profile that transitions through various woody, herbal, and citrus notes.

As a THC-dominant hybrid-indica, Charlie's Angel produces effects characterized primarily by relaxation, calmness, and a directed sense of focus. These physiological and psychological outcomes make the strain particularly effective for managing pain, alleviating stress, and assisting with sleep. The balance achieved by its cannabinoid profile ensures a consistent experience, cementing its role as a versatile option in both recreational and therapeutic applications.